GlassScriptPhysician profile
Christine Doyle
NPI 1871888966
$1,522.62
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $178 · 2021: $684 · 2022: $326 · 2023: $115 · 2024: $75.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $353.34 | 2021 | |
| Abbvie INC. | $201.72 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Organon LLC | $128.38 | 2021-2024 | Nexplanon |
| Myovant Sciences INC. | $103.40 | 2021-2022 | |
| Astellas Pharma US INC | $98.02 | 2020-2023 | Veozah |
| Therapeuticsmd, INC. | $73.90 | 2020-2021 | |
| Boston Scientific Corporation | $66.21 | 2021-2022 | |
| Roche Diagnostics Corporation | $62.43 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $54.68 | 2020-2021 | |
| Pfizer INC. | $54.09 | 2022-2024 | |
| Covidien LP | $43.47 | 2019 | |
| Hologic Sales and Service, LLC | $39.66 | 2023-2024 | Coolseal Generator, Aptima |
| Exeltis, USA INC. | $38.63 | 2022 | |
| Minerva Surgical, INC | $33.43 | 2019 | |
| Biogen, INC. | $25.78 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $22.82 | 2020 | |
| Davol INC. | $21.52 | 2021 | |
| Agile Therapeutics, INC. | $20.72 | 2021 | |
| Myriad Women'S Health, INC. | $20.59 | 2023 | Myrisk |
| Channel Medsystems, INC. | $16.52 | 2023 | |
| Dysis Medical, INC. | $15.63 | 2020 | |
| Alnylam Pharmaceuticals INC. | $15.12 | 2021 | |
| Aspira Women'S Health INC | $12.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Doyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.